PDIA3 and neoplasm: Overexpression of PDIA3 has been reported in various tumors, including melanomas, cervical carcinoma, ovarian carcinoma, esophageal squamous cell carcinoma, and hepatocellular carcinoma, and is associated with tumor progression, metastasis and poor patient survival rate[22-24,32-35].